Delivery Order SPE2DB22D1106-SPE2DB24FEDE8
- Not listed
- This is a $23,269.93 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,308,419 units of the prescription drug UROXATRAL 10 MG TABLET 100S. The contract has an ultimate completion date of August 1, 2024 and does not use a set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products to federal agencies and healthcare...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,889.55, is for the delivery of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is October 27, 2023. This award does not have a set-aside designation,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Uroxatral 10 mg tablets. The $11,916.73 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside...
- This is a $22,429.40 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 22, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,025.13, is a delivery order for the supply of 4563551117 UROXATRAL 10 MG TABLET 100S. The contract has a firm fixed price and an ultimate completion date of February 6, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $11,796.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has a completion date of February 13, 2024 and is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
- This is a $43,711.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,562,473,580 units of the prescription drug UROXATRAL 10 mg tablets. The contract has an ultimate completion date of October 16, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $20,326.60 firm fixed-price contract is for the delivery of Uroxatral 10 mg tablets. The contract has an ultimate completion date of July 11, 2023 and was awarded on July 10, 2023. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Uroxatral 10 mg tablets. The award has a ceiling value of $9,596.91 and a performance period through April 2, 2024. The contract is a firm fixed price delivery order, and no set-aside designation was used. AmerisourceBergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, with a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $76,085.33, is for the delivery of Uroxatral 10 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through September 22, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEDE8Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract has a potential value of $10,896.18 and a completion date of March 6, 2024. It is for the supply of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is not associated with any set-aside designation. The company also holds a larger indefinite delivery contract with DLA, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 3/5/24 |